Showing results (151-160 of 330) with videos related to
Sort By:
Pageof 33
JTO Clinical and Research Reports|November 18, 2020
Coronavirus Disease 2019 Infection in a Patient Population with Lung Cancer: Incidence, Presentation, and Alternative Diagnostic ConsiderationsAndrew J Piper-Vallillo, Meghan J Mooradian, Catherine B Meador, et al.Cell Reports|December 16, 2017
Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient CareDavid P Kodack, Anna F Farago, Anahita Dastur, et al.Neuro-Oncology|July 24, 2014
Significance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non-small cell lung cancer treated with radiotherapy for brain metastasesKimberley S Mak, Justin F Gainor, Andrzej Niemierko, et al.Clinical Lung Cancer|November 12, 2019
Computed Tomography Imaging Features and Distribution of Metastases in ROS1-rearranged Non-Small-cell Lung CancerSubba R Digumarthy, Dexter P Mendoza, Jessica J Lin, et al.Cancer|March 27, 2018
Long-term safety and survival with gefitinib in select patients with advanced non-small cell lung cancer: Results from the US IRESSA Clinical Access Program (ICAP)Fred R Hirsch, Lecia V Sequist, Ira Gore, et al.Biorxiv : the Preprint Server for Biology|July 9, 2025
Multimodal profiling of proinflammatory protease activity identifies caspase-1 as a target for lung cancer interceptionCathy S Wang, Qian Zhong, Shih-Ting Wang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 15, 2016
Clinicopathologic Features of NSCLC Diagnosed During Pregnancy or the Peripartum Period in the Era of Molecular GenotypingIbiayi Dagogo-Jack, Justin F Gainor, Rebecca L Porter, et al.Journal of Environmental Management|December 29, 2015
Isolation of hydrocarbon-degrading and biosurfactant-producing bacteria and assessment their plant growth-promoting traitsMagdalena Pacwa-Płociniczak, Tomasz Płociniczak, Joanna Iwan, et al.The Oncologist|May 7, 2022
Phase II Study of Cabozantinib in Patients With Bone MetastasisEdwin Choy, Gregory M Cote, M Dror Michaelson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trialsDavid M Jackman, Vincent A Miller, Leigh-Anne Cioffredi, et al.Pageof 33